A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, May 2005

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users
patent: 214 patents

facebook: 1 Facebook page
wikipedia: 6 Wikipedia pages
guideline: 1 clinical guideline source

Readers on

mendeley: 497 Mendeley

So far, Altmetric has seen 214 patents that reference this research output.

Gene therapy for macular degeneration

Grant US-12702721-B2

United States of America

11 Aug 2026

MODIFIED UROKINASE-TYPE PLASMINOGEN ACTIVATOR POLYPEPTIDES AND METHODS OF USE

Application EP-4763226-A2

European Patent Office

24 Jun 2026

Systems and methods for computing with private healthcare data

Grant US-12619782-B2

United States of America

05 May 2026

Dosing regimens

Grant US-12528836-B2

United States of America

20 Jan 2026

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 210 additional patents.